News & Updates
Filter by Specialty:
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
29 May 2022
Accelerated administration of daratumumab, an anti-CD3 monoclonal antibody approved for multiple myeloma, is safe and well tolerated when given following at least two standard infusions, suggest the results of a recent study.
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma
29 May 2022
Chemoradiotherapy improves disease control in muscle-invasive bladder cancer
28 May 2022
Chemotherapy with 5-fluorouracil (5FU) and mitomycin C (MMC), when combined with radiotherapy, leads to better locoregional control over a 10-year window in patients with muscle-invasive bladder cancer (MIBC), a recent study has found.
